Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21

BACKGROUND. A combination of serotonin receptor (5-hydroxytryptamine receptor type 3) antagonists, NK-1 receptor antagonist, and steroid improves the complete response (CR) of chemotherapy-induced nausea and vomiting (CINV) in cancer patients. Ramosetron’s efficacy in this triple combination regimen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Kim, Hyo Jung, Shin, Sang Won, Song, Eun-Kee, Lee, Na-Ri, Kim, Jun Suk, Ahn, Jin Seok, Yun, Hwan-Jung, Cho, Yo-Han, Park, Keon Uk, Kim, Si-Young, Jang, Joung Soon, Kim, Sang-We, Lee, Hyun Woo, Lee, Se Ryeon, Kim, Yang Soo, Lee, Soon Nam, Ko, Yoon Ho, Kim, Hwa Jung, Kang, Jin-Hyoung
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Symptom Management and Supportive Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679080/
https://ncbi.nlm.nih.gov/pubmed/26512046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados